Deknatel launches heart instruments range:
This article was originally published in Clinica
Deknatel Snowden Pencer launched a range of instruments for minimally invasive coronary bypass grafting at the American Association of Thoracic Surgeons meeting. The instruments for internal mammary artery procedures include forceps, scissors, needle holders, rib spreaders and a three-chip camera. Deknatel, which is based in Tucker, Georgia, is being purchased by Genzyme (see Clinica No 708, p 13).
You may also be interested in...
Policy experts predicted how the incoming Biden administration will handle health care issues at a recent Alliance for Health Policy webinar. Rachel Nuzum, VP of state and federal policy at The Commonwealth Fund, said telehealth could be a priority.
The China National Biotec Group has filed the first application in China for the broad use of a COVID-19 vaccine, days after the national regulatory agency released review guidelines for the conditional approval of such products.
More patent-related turbulence appears ahead for Novartis’s sacubitril/valsartan combination in India, with Torrent emerging as the new challenger. The companies are engaged in a legal battle and the Indian firm is also seeking a revocation of the patent on the star heart failure treatment.